No abstract available
MeSH terms
-
Aged
-
Aged, 80 and over
-
Cardiovascular Diseases / epidemiology
-
Cardiovascular Diseases / mortality
-
Cholesterol, LDL / blood
-
Cohort Studies
-
Diabetes Complications / epidemiology
-
Diabetes Complications / mortality
-
Diabetes Mellitus / drug therapy
-
Diabetes Mellitus / mortality
-
Diabetes Mellitus / therapy*
-
Double-Blind Method
-
Fluorobenzenes / administration & dosage
-
Fluorobenzenes / therapeutic use*
-
Follow-Up Studies
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
-
Multicenter Studies as Topic*
-
Placebos
-
Prospective Studies
-
Pyrimidines / administration & dosage
-
Pyrimidines / therapeutic use*
-
Randomized Controlled Trials as Topic*
-
Renal Dialysis* / mortality
-
Risk Factors
-
Rosuvastatin Calcium
-
Sulfonamides / administration & dosage
-
Sulfonamides / therapeutic use*
-
Time Factors
Substances
-
Cholesterol, LDL
-
Fluorobenzenes
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors
-
Placebos
-
Pyrimidines
-
Sulfonamides
-
Rosuvastatin Calcium